Issue 30, 2022

Development of small cyclic peptides targeting the CK2α/β interface

Abstract

In this work, an iterative cycle of enzymatic assays, X-ray crystallography, molecular modelling and cellular assays were used to develop a functionalisable chemical probe for the CK2α/β PPI. The lead peptide, P8C9, successfully binds to CK2α at the PPI site, is easily synthesisable and functionalisable, highly stable in serum and small enough to accommodate further optimisation.

Graphical abstract: Development of small cyclic peptides targeting the CK2α/β interface

Supplementary files

Article information

Article type
Communication
Submitted
04 Feb 2022
Accepted
21 Mar 2022
First published
21 Mar 2022
This article is Open Access
Creative Commons BY license

Chem. Commun., 2022,58, 4791-4794

Development of small cyclic peptides targeting the CK2α/β interface

E. L. Atkinson, J. Iegre, C. D’Amore, P. Brear, M. Salvi, M. Hyvönen and D. R. Spring, Chem. Commun., 2022, 58, 4791 DOI: 10.1039/D2CC00707J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements